Answer
Tafamidis meglumine has not been studied in patients with severe hepatic impairment, and caution is recommended.
Sources for this answer
- Vyndaqel 20 mg soft capsulesPfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 18Document updated
Sources checked